Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-15-005526
Filing Date
2015-10-14
Accepted
2015-10-14 17:17:27
Documents
6
Period of Report
2015-10-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K gff6k_101415.htm 6-K 12357
2 EXHIBIT 99.1 exh_991.htm EX-99.1 131681
3 EXHIBIT 99.2 exh_992.htm EX-99.2 309236
4 EXHIBIT 99.3 exh_993.htm EX-99.3 8711
5 EXHIBIT 99.4 exh_994.htm EX-99.4 8713
6 GRAPHIC logo.jpg GRAPHIC 14175
  Complete submission text file 0001171843-15-005526.txt   491353
Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3
Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 151158671
SIC: 2834 Pharmaceutical Preparations